LEA/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
male |
7 days
| 3 |
209.7 |
ug/g |
6.87 |
11.9 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107406 |
3086 |
LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
male |
112 days
| 3 |
1153.3 |
ug/g |
71.65 |
124.1 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107412 |
3086 |
LEA/Hok |
liver copper weight to liver wet weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
female |
90 days
| 3 |
3.7 |
ug/g |
0.17 |
0.3 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107414 |
3086 |
LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
female |
224 days
| 3 |
631.1 |
ug/g |
113.1 |
195.9 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107417 |
3086 |
LEA/Hok |
serum copper level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood copper amount |
male |
168 days
| 3 |
24.9 |
umol/l |
1.27 |
2.2 |
graphite furnace atomic absorption spectrometry |
0.0 |
0 |
|
|
107503 |
3086 |
LEC/Hok |
serum copper level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood copper amount |
male |
168 days
| 3 |
5.0 |
umol/l |
0.92 |
1.6 |
graphite furnace atomic absorption spectrometry |
0.0 |
0 |
|
|
107505 |
3086 |
LEA/Hok |
urine copper level to urine creatinine level ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
urine copper amount |
female |
168 days
| 3 |
3.76 |
umol/umol Cr |
0.82 |
1.42 |
graphite furnace atomic absorption spectrometry |
0.0 |
0 |
|
urine copper level to urine creatinine level ratio (CMO:0003493) |
107509 |
3086 |
LEA/Hok |
serum ceruloplasmin level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood ceruloplasmin amount |
female |
28 days
| 3 |
589.0 |
mg/l |
17.9 |
31.0 |
serum p-phenylenediamine oxidase activity assay |
0.0 |
0 |
serum p-phenylenediamine oxidase activity assay (MMO:0000728) |
|
107524 |
3086 |
LEA/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
female |
2 days
| 3 |
198.6 |
ug/g |
9.41 |
16.3 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107405 |
3086 |
LEC/Hok |
liver copper weight to liver wet weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
female |
90 days
| 3 |
223.1 |
ug/g |
3.93 |
6.8 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107415 |
3086 |
LEA/Hok |
serum copper level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood copper amount |
female |
168 days
| 3 |
28.2 |
umol/l |
3.0 |
5.2 |
graphite furnace atomic absorption spectrometry |
0.0 |
0 |
|
|
107504 |
3086 |
LEA/Hok |
serum ceruloplasmin level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood ceruloplasmin amount |
male |
7 days
| 3 |
205.8 |
mg/l |
26.38 |
45.7 |
serum p-phenylenediamine oxidase activity assay |
0.0 |
0 |
serum p-phenylenediamine oxidase activity assay (MMO:0000728) |
|
107515 |
3086 |
LEA/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
male |
2 days
| 3 |
200.0 |
ug/g |
3.87 |
6.7 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107404 |
3086 |
LEA/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
female |
7 days
| 3 |
204.0 |
ug/g |
9.64 |
16.7 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107407 |
3086 |
LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
female |
28 days
| 3 |
380.0 |
ug/g |
56.52 |
97.9 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107411 |
3086 |
LEA/Hok |
serum copper level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood copper amount |
male |
28 days
| 3 |
13.6 |
umol/l |
2.37 |
4.1 |
graphite furnace atomic absorption spectrometry |
0.0 |
0 |
|
|
107501 |
3086 |
LEA/Hok |
urine copper level to urine creatinine level ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
urine copper amount |
male |
28 days
| 3 |
2.78 |
umol/umol Cr |
0.67 |
1.16 |
graphite furnace atomic absorption spectrometry |
0.0 |
0 |
|
urine copper level to urine creatinine level ratio (CMO:0003493) |
107506 |
3086 |
LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
male |
2 days
| 3 |
597.8 |
ug/g |
27.37 |
47.4 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107408 |
3086 |
LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
female |
112 days
| 3 |
1201.7 |
ug/g |
59.81 |
103.6 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107413 |
3086 |
LEA/Hok |
urine copper level to urine creatinine level ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
urine copper amount |
male |
168 days
| 3 |
1.07 |
umol/umol Cr |
0.29 |
0.5 |
graphite furnace atomic absorption spectrometry |
0.0 |
0 |
|
urine copper level to urine creatinine level ratio (CMO:0003493) |
107507 |
3086 |
LEA/Hok |
urine copper level to urine creatinine level ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
urine copper amount |
female |
28 days
| 3 |
2.8 |
umol/umol Cr |
0.67 |
1.16 |
graphite furnace atomic absorption spectrometry |
0.0 |
0 |
|
urine copper level to urine creatinine level ratio (CMO:0003493) |
107508 |
3086 |
LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
male |
224 days
| 3 |
861.9 |
ug/g |
13.28 |
23.0 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107416 |
3086 |
LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
female |
2 days
| 3 |
627.4 |
ug/g |
43.19 |
74.8 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107409 |
3086 |
LEA/Hok |
serum copper level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood copper amount |
female |
28 days
| 3 |
14.1 |
umol/l |
0.52 |
0.9 |
graphite furnace atomic absorption spectrometry |
0.0 |
0 |
|
|
107502 |
3086 |
LEA/Hok |
serum ceruloplasmin level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood ceruloplasmin amount |
female |
7 days
| 3 |
192.2 |
mg/l |
8.31 |
14.4 |
serum p-phenylenediamine oxidase activity assay |
0.0 |
0 |
serum p-phenylenediamine oxidase activity assay (MMO:0000728) |
|
107522 |
3086 |
LEA/Hok |
serum ceruloplasmin level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood ceruloplasmin amount |
male |
28 days
| 3 |
552.1 |
mg/l |
48.84 |
84.6 |
serum p-phenylenediamine oxidase activity assay |
0.0 |
0 |
serum p-phenylenediamine oxidase activity assay (MMO:0000728) |
|
107523 |
3086 |
LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
hepatic copper amount |
male |
28 days
| 3 |
320.1 |
ug/g |
32.62 |
56.5 |
flame atomic absorption spectrometry |
0.0 |
0 |
|
|
107410 |
3086 |